Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HRMY Harmony Biosciences Holdings, Inc.

Post-Mkt 08-07 18:22:07 EDT

38.41

-0.34

-0.88%

盘后38.00

-0.41-1.07%

17:16 EDT

High39.43	Low38.20	Vol994.52K
Open39.20	D1 Closing38.75	Amplitude3.17%
Mkt Cap2.24B	Tradable Cap1.96B	Total Shares58.24M
T/O38.49M	T/O Rate1.94%	Tradable Shares51.15M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HRMY","market":"US","secType":"STK","nameCN":"Harmony Biosciences Holdings, Inc.","latestPrice":38.41,"timestamp":1786132800000,"preClose":38.75,"halted":0,"volume":994520,"hourTrading":{"tag":"盘后","latestPrice":38,"preClose":38.41,"latestTime":"17:16 EDT","volume":28988,"amount":1113418.78926,"timestamp":1786137377727,"change":-0.41,"changeRate":-0.010674,"amplitude":0.010674},"delay":0,"changeRate":-0.008774193548387184,"floatShares":51145954,"shares":58236393,"eps":3.09102,"marketStatus":"Post-Mkt","change":-0.34,"latestTime":"08-07 18:22:07 EDT","open":39.2,"high":39.43,"low":38.2,"amount":38486259.17352,"amplitude":0.031742,"askPrice":39.3,"askSize":100,"bidPrice":38,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":3.09102,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1786147200000},"marketStatusCode":4,"adr":0,"listingDate":1597809600000,"exchange":"NASDAQ","adjPreClose":38.75,"preHourTrading":{"tag":"盘前","latestPrice":39.14,"preClose":38.75,"latestTime":"09:29 EDT","volume":2093,"amount":81292.551158,"timestamp":1786109341085,"change":0.39,"changeRate":0.010065,"amplitude":0.032},"postHourTrading":{"tag":"盘后","latestPrice":38,"preClose":38.41,"latestTime":"17:16 EDT","volume":28988,"amount":1113418.78926,"timestamp":1786137377727,"change":-0.41,"changeRate":-0.010674,"amplitude":0.010674},"volumeRatio":0.887235,"impliedVol":0.4437,"impliedVolPercentile":0.2311},"requestUrl":"/m/hq/s/HRMY","defaultTab":"news","newsList":[{"id":"2657395516","title":"Praxis Precision Q2 Net Loss Widens on Higher Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2657395516","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657395516?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:12","pubTimestamp":1786018371,"startTime":"0","endTime":"0","summary":"Praxis Precision Q2 net loss widens on higher expensesOverviewUS CNS drug developer's Q2 net loss widened yr/yr on higher operating expensesCompany ended Q2 with $1.4 bln in cash and investments, fund","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4430NP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GHRS","IE00B4R5TH58.HKD","LU0889565916.HKD","BK4139","VNDA","BK4539","IE00BJT1NW94.SGD","BK4007","PRAX","IBRN","PSIL","IE0002141913.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0320765992.SGD","IE0009355771.USD","HRMY","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657241915","title":"Harmony Biosciences is Maintained at Hold by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2657241915","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657241915?lang=en_us&edition=fundamental","pubTime":"2026-08-06 02:27","pubTimestamp":1785954420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HRMY/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657388549","title":"UBS Reaffirms Their Hold Rating on Harmony Biosciences Holdings (HRMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657388549","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657388549?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:16","pubTimestamp":1785928608,"startTime":"0","endTime":"0","summary":"In a report released today, So Youn Shim from UBS maintained a Hold rating on Harmony Biosciences Holdings, with a price target of $37.00. Harmony ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-reaffirms-their-hold-rating-on-harmony-biosciences-holdings-hrmy-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-reaffirms-their-hold-rating-on-harmony-biosciences-holdings-hrmy-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657600545","title":"Harmony Biosciences Says New Data Supports Neurology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2657600545","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657600545?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:56","pubTimestamp":1785927383,"startTime":"0","endTime":"0","summary":"Harmony Biosciences stock jumped after record Q2 revenue, an earnings beat, strong WAKIX sales and updated analyst price targets.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/08/60942069/harmony-biosciences-says-new-data-supports-neurology-pipeline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","HRMY","BK4181","KBWY","PK","BK4217","SMA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657543223","title":"Harmony Biosciences price target raised to $30 from $28 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657543223","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657543223?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:32","pubTimestamp":1785925937,"startTime":"0","endTime":"0","summary":"BofA analyst Jason Gerberry raised the firm’s price target on Harmony Biosciences (HRMY) to $30 from $28 and keeps an Underperform rating on the sh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/harmony-biosciences-price-target-raised-to-30-from-28-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/harmony-biosciences-price-target-raised-to-30-from-28-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657512554","title":"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Lemaitre Vascular (LMAT) and Harmony Biosciences Holdings (HRMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657512554","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657512554?lang=en_us&edition=fundamental","pubTime":"2026-08-05 16:50","pubTimestamp":1785919817,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Abbott Laboratories (ABT), Lemaitre Vascular (LMAT) and Harmony B...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-lemaitre-vascular-lmat-and-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-lemaitre-vascular-lmat-and-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","HCSG","LU2089984988.USD","LU2133065610.SGD","SG9999004303.SGD","LU0170899867.USD","LU2237957811.SGD","LU2237957902.USD","LU1989763427.SGD","LU0882574055.USD","LU0289739699.SGD","LU2468319806.SGD","BK4533","LU1023059063.AUD","LU0432979614.USD","SG9999002224.SGD","TMED","ABT","IHI","BK4588","LABU","LU1057294990.SGD","BK4585","LU0266013472.USD","BK4137","IE0002141913.USD","LU0114720955.EUR","LU0122379950.USD","LU0128526141.USD","PJP","XLV","LU0058720904.USD","BK4566","LU0234572021.USD","LU1721429402.USD","XBI","BK4504","BK4568","LU2211815571.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","BK4082","LMAT","BK4592","IE00BFTCPJ56.SGD","LU1721429741.USD","LU1989763690.USD","SGXZ41872573.SGD","HRMY","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657404561","title":"Ultragenyx Q2 Revenue Rises 28% to Record High, Net Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2657404561","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657404561?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:18","pubTimestamp":1785874711,"startTime":"0","endTime":"0","summary":"Ultragenyx Q2 revenue rises 28% to record high, net loss narrowsOverviewUS biopharma for rare diseases reported Q2 revenue up yr/yr to highest in company historyNet loss for Q2 narrowed yr/yr, with lo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N441167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","BK4007","RYTM","PSCH","MEDI","BK4585","BK4139","RARE","HRMY","BK4588","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657056901","title":"Rigel Pharmaceuticals Q2 Revenue Rises on Strong Product Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2657056901","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657056901?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:11","pubTimestamp":1785874311,"startTime":"0","endTime":"0","summary":"Rigel Pharmaceuticals Q2 revenue rises on strong product demandOverviewBiotechnology firm's Q2 revenue rose, with net product sales up 14% yr/yrQ2 net income fell from prior year due to absence of $40","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N44113X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4139","MEDI","RYTM","HRMY","BK4007","RIGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656551254","title":"Harmony Biosciences Shares Rise After Q2 Earnings, Product Revenue Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2656551254","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656551254?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:35","pubTimestamp":1785850509,"startTime":"0","endTime":"0","summary":"Harmony Biosciences  shares were up 6.2% in early Tuesday trading after the company posted higher Q2 results.The company reported Q2 earnings of $1.28 per diluted share, up from $0.68 a year earlier.Analysts polled by FactSet expected $0.96.Net product revenue for the quarter ended June 30 was $261.3 million, up from $200.5 million a year earlier.Analysts expected revenue of $250.8 million.Harmony reiterated its 2026 WAKIX net revenue guidance of $1.0 billion to $1.04 billion.As of June 30, the company said it had $962.5 million in cash, cash equivalents and investments.Price: 37.81, Change: +2.21, Percent Change: +6.19","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656551600","title":"Harmony Biosciences Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656551600","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656551600?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:31","pubTimestamp":1785850309,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings Inc reports results for the quarter ended June 30 - Earnings SummaryHarmony Biosciences Holdings IncHRMY.OQreported quarterly adjusted earnings of $1.28 per share for the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4411QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656532815","title":"Harmony Biosciences Q2 WAKIX Revenue Beats on Patient Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2656532815","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656532815?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:54","pubTimestamp":1785844450,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Q2 WAKIX revenue beats on patient growthOverviewUS pharmaceutical firm's Q2 WAKIX revenue grew 30% yr/yr, beating analyst expectationsPretax profit for Q2 beat analyst estimatesCom","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N4410FZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656553561","title":"GUIDANCE: (HRMY) Harmony Biosciences Expects 2026 Wakix Net Revenue Range $1.0B to $1.04B","url":"https://stock-news.laohu8.com/highlight/detail?id=2656553561","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656553561?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:41","pubTimestamp":1785843678,"startTime":"0","endTime":"0","summary":"GUIDANCE: (HRMY) Harmony Biosciences Expects 2026 Wakix Net Revenue Range $1.0B to $1.04B","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656553535","title":"Earnings Flash (HRMY) Harmony Biosciences Posts Q2 EPS $1.28, vs. FactSet Est of $0.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2656553535","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656553535?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:39","pubTimestamp":1785843580,"startTime":"0","endTime":"0","summary":"Earnings Flash (HRMY) Harmony Biosciences Posts Q2 EPS $1.28, vs. FactSet Est of $0.96","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656558033","title":"Harmony Biosciences Q2 EPS $1.28 Beats $0.94 Estimate, Sales $261.300M Beat $248.406M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656558033","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656558033?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:32","pubTimestamp":1785843159,"startTime":"0","endTime":"0","summary":"Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $1.28 per share which beat the analyst consensus estimate of $0.94 by 36.17 percent. This is a 39.13 percent increase over earnings of $0.92 per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60901839/harmony-biosciences-q2-eps-1-28-beats-0-94-estimate-sales-261-300m-beat-248-406m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656558211","title":"Harmony Biosciences Q2 FY26 Net Income Rises 90% to $75.4 Million; Revenue Climbs 30% to $261.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656558211","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656558211?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:30","pubTimestamp":1785843032,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Q2 FY26 net income rises 90% to $75.4 million; revenue climbs 30% to $261.3 millionHarmony Biosciences posted Q2 net product revenue of $261.3 million, up 30% year over year, with ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL7mv4t6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2T93.GBP","SG9999014005.SGD","LU2095319765.USD","HRMY","BK4585","IE00BN0W2V16.EUR","BK4588","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014013.SGD","BK4112","LU0314104364.USD","BCDF","LU2210150020.SGD","SG9999014021.USD","SG9999014039.USD","BK4007","IE00BKPKM429.USD","IE00B64PRP62.GBP","NDAQ","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656378950","title":"Harmony Biosciences : Mizuho Raises Target Price to $51 from $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2656378950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656378950?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:37","pubTimestamp":1785753428,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN440136:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656111963","title":"Harmony Biosciences (HRMY) Stock Looks Below Fair Value On Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2656111963","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656111963?lang=en_us&edition=fundamental","pubTime":"2026-08-02 06:29","pubTimestamp":1785623367,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings has delivered a 30.8% total return over the past 5 years. However, recent share price softness and a strong overall value score suggest the stock may still be pricing in a relatively cautious view. The question for investors is whether the recent drift in performance lines up with what the broader valuation checks are implying.\n\nOver 5 years, Harmony Biosciences Holdings has returned 30.8%, which points to a moderate payoff for investors who stayed invested over...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrmy/harmony-biosciences-holdings/news/harmony-biosciences-hrmy-stock-looks-below-fair-value-on-ear","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrmy/harmony-biosciences-holdings/news/harmony-biosciences-hrmy-stock-looks-below-fair-value-on-ear","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193789133","title":"Earning Preview: Harmony Biosciences Holdings, Inc. this quarter’s revenue is expected to increase by 22.01%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1193789133","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193789133?lang=en_us&edition=fundamental","pubTime":"2026-07-29 11:56","pubTimestamp":1785297410,"startTime":"0","endTime":"0","summary":"Abstract Harmony Biosciences Holdings, Inc. will report second-quarter results on August 4, 2026 Pre-Market; the preview below summarizes market expectations for revenue, margins, net profit and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Harmony Biosciences Holdings, Inc. this quarter’s revenue is expected to increase by 22.01%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653798530","title":"Harmony Biosciences Interim Principal Financial Officer Stephen Mollichella Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2653798530","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653798530?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:04","pubTimestamp":1784750684,"startTime":"0","endTime":"0","summary":"Harmony Biosciences interim principal financial officer Stephen Mollichella files initial beneficial ownership statementHarmony Biosciences initial Form 3 shows interim principal financial officer Ste","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDLbRDBr9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653769272","title":"Harmony Biosciences to Report Q2 Results Before US Market Open, Host Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2653769272","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653769272?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:06","pubTimestamp":1784635594,"startTime":"0","endTime":"0","summary":"Harmony Biosciences to report Q2 results before US market open, host conference call and webcastHarmony Biosciences schedules second-quarter 2026 results release for Aug. 4, 2026, before the U.S. mark","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL3w87CG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014005.SGD","LU0314104364.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD","HRMY","SG9999014039.USD","BK4007","BCDF","IE00B3QW5Z07.USD","NDAQ","IE00BGHQF748.EUR","BK4588","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4585","BK4112","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.harmonybiosciences.com","stockEarnings":[{"period":"1week","weight":0.0806},{"period":"1month","weight":0.0128},{"period":"3month","weight":0.2504},{"period":"6month","weight":0.0397},{"period":"1year","weight":0.1177},{"period":"ytd","weight":0.0355}],"compareEarnings":[{"period":"1week","weight":0.0362},{"period":"1month","weight":0.0279},{"period":"3month","weight":0.0419},{"period":"6month","weight":0.1129},{"period":"1year","weight":0.2146},{"period":"ytd","weight":0.1271}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.035612},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.051691},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.016911},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.04592},{"month":5,"riseRate":0.666667,"avgChangeRate":0.043963},{"month":6,"riseRate":0.666667,"avgChangeRate":0.019037},{"month":7,"riseRate":0.666667,"avgChangeRate":0.02924},{"month":8,"riseRate":0.833333,"avgChangeRate":0.066125},{"month":9,"riseRate":0.5,"avgChangeRate":-0.023406},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.006378},{"month":11,"riseRate":0.833333,"avgChangeRate":0.105341},{"month":12,"riseRate":0.5,"avgChangeRate":0.02881}],"exchange":"NASDAQ","name":"Harmony Biosciences Holdings, Inc.","nameEN":"Harmony Biosciences Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Harmony Biosciences Holdings, Inc.(HRMY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Harmony Biosciences Holdings, Inc.,HRMY,Harmony Biosciences Holdings, Inc.股票,Harmony Biosciences Holdings, Inc.股票老虎,Harmony Biosciences Holdings, Inc.股票老虎国际,Harmony Biosciences Holdings, Inc.行情,Harmony Biosciences Holdings, Inc.股票行情,Harmony Biosciences Holdings, Inc.股价,Harmony Biosciences Holdings, Inc.股市,Harmony Biosciences Holdings, Inc.股票价格,Harmony Biosciences Holdings, Inc.股票交易,Harmony Biosciences Holdings, Inc.股票购买,Harmony Biosciences Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Harmony Biosciences Holdings, Inc.(HRMY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}